We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Quantum Phar. | LSE:QP. | London | Ordinary Share | GB00BRTL8Q42 | ORD 10P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 84.2374 | 84.00 | 84.75 | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
TIDMQP.
RNS Number : 1371P
Quantum Pharma PLC
14 November 2016
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES ----------------------------------------------------------------------------------------- 1. Identity of the issuer or Quantum Pharma PLC the underlying issuer of existing shares to which voting rights are attached: ----------------------------------------------------------- ---------------------------- 2 Reason for the notification (please tick the appropriate box or boxes): ----------------------------------------------------------------------------------------- An acquisition or disposal of voting rights --------------------------------------------------------------- ------------------------ An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached --------------------------------------------------------------- ------------------------ An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments --------------------------------------------------------------- ------------------------ An event changing the breakdown of voting rights X --------------------------------------------------------------- ------------------------ Other (please specify): ---------------------------------------------------------- --- ------------------------ 3. Full name of person(s) AXA Investment Managers subject to the notification obligation: ----------------------------------------------------------- ---------------------------- 4. Full name of shareholder(s) (if different from 3.): ----------------------------------------------------------- ---------------------------- 5. Date of the transaction 11(th) November 2016 and date on which the threshold is crossed or reached: ----------------------------------------------------------- ---------------------------- 6. Date on which issuer 14(th) November 2016 notified: ----------------------------------------------------------- ---------------------------- 7. Threshold(s) that is/are crossed or reached: 5.00 % ----------------------------------------------------------- ---------------------------- 8. Notified details: -------------------------------------------------------------------------------------------- A: Voting rights attached to shares -------------------------------------------------------------------------------------------- Class/type Situation previous Resulting situation after the of to the triggering triggering transaction shares transaction if possible using the ISIN CODE -------------- ---------------------- ---------------------------------------------------- Number Number Number Number of % of voting of of of shares voting rights Shares Voting rights Rights -------------- ---------- ---------- ----------- ------------------- ------------------ Direct Direct Indirect Direct Indirect -------------- ---------- ---------- ----------- ------- ---------- ------- --------- 0.00 4.60 GB00BRTL8Q42 7,775,000 7,775,000 0 0 7,775,000 % % -------------- ---------- ---------- ----------- ------- ---------- ------- --------- B: Qualifying Financial Instruments -------------------------------------------------------------------------- Resulting situation after the triggering transaction -------------------------------------------------------------------------- Type of financial Expiration Exercise/ Number of % of voting instrument date Conversion voting rights Period rights that may be acquired if the instrument is exercised/ converted. ------------------ ----------- ------------ ------------- ------------ C: Financial Instruments with similar economic effect to Qualifying Financial Instruments ------------------------------------------------------------------------------------------- Resulting situation after the triggering transaction ------------------------------------------------------------------------------------------- Type of financial Exercise Expiration Exercise/ Number of % of voting instrument price date Conversion voting rights rights period instrument refers to ------------------ --------- ----------- ------------ --------------- ---------------- Nominal Delta ------------------ --------- ----------- ------------ --------------- -------- ------ Total (A+B+C) ------------------------------------------------------ Number of voting rights Percentage of voting rights ------------------------ ---------------------------- 7,775,000 4.60 % ------------------------ ---------------------------- 9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable: ---------------------------------------------------------------------------------------------- Proxy Voting: ---------------------------------------------------------------------------------------------- 10. Name of the proxy holder: ------------------------------------------------------------- ------------------------------- 11. Number of voting rights proxy holder will cease to hold: ------------------------------------------------------------- ------------------------------- 12. Date on which proxy holder will cease to hold voting rights: ------------------------------------------------------------- ------------------------------- This notification is made 13. Additional information: following the change of the total number of voting rights of Quantum Pharma PLC after the result of placing and admission of new shares on 11(th) November 2016. ------------------------------------------------------------- ------------------------------- 14. Contact name: Pascaline HAYE ------------------------------------------------------------- ------------------------------- 15. Contact telephone number: +33 1 44 45 77 01 ------------------------------------------------------------- -------------------------------
This information is provided by RNS
The company news service from the London Stock Exchange
END
HOLGGGWGGUPQGQC
(END) Dow Jones Newswires
November 14, 2016 11:20 ET (16:20 GMT)
1 Year Quantum Phar. Chart |
1 Month Quantum Phar. Chart |
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions